Increased IL-31 serum levels were detected in patients with CTCL, compared to healthy controls, and in patients with advanced-stage CTCL, compared to those with early-stage disease [32]. This evidence concerns the gene IL31 and primary cutaneous T-cell non-Hodgkin lymphoma.